Bayer's Founding: The Annihilator (1/5): A Marriage Between Good and Evil
Translated from German and summarized by DistantNews. Read the original for the full story.
At a glance
- Ten years ago, Bayer AG acquired Monsanto, the manufacturer of glyphosate, an acquisition that nearly led to the company's downfall.
- The article series, "The Annihilator – How Bayer Swallowed Glyphosate," explores this pivotal event and its consequences.
- The first episode discusses the founding of Bayer, the roles of its founders, and the significance of Aspirin's invention.
This is the introductory episode of DIE ZEIT's compelling podcast series, "The Annihilator – How Bayer Swallowed Glyphosate," which revisits the fateful decision ten years prior for Bayer AG to acquire Monsanto, the controversial producer of glyphosate. The acquisition, which almost crippled the German chemical and pharmaceutical giant, is presented as a watershed moment, the consequences of which continue to unfold.
Jens Tönnesmann and Andreas Sentker, the hosts and researchers, guide listeners through the complex history of Bayer. In this first installment, they trace the company's origins, detailing how a merchant and a dyer laid the foundation for a global conglomerate. The narrative intriguingly weaves in the influence of heroin, the world wars, and even football, alongside the groundbreaking invention of Aspirin, highlighting how this single product was a multi-faceted breakthrough for the company.
DIE ZEIT, a respected German weekly known for its in-depth analysis and critical reporting, frames this series as an essential examination of corporate ambition, ethical compromise, and the long shadow cast by controversial products. From a German perspective, the story of Bayer and Monsanto is not merely a business case; it's a deep dive into the responsibilities of global corporations, the societal impact of their products, and the potential for even established giants to face existential crises. The podcast promises a thorough, critical investigation into how Bayer's pursuit of growth led it down a path that nearly consumed it.
Originally published by Die Zeit in German. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.